Literature DB >> 18445528

Efficient synthesis and evaluation of bimodal ligand NETA.

Hyun-Soon Chong1, Hyun A Song, Noah Birch, Thien Le, Sooyoun Lim, Xiang Ma.   

Abstract

The efficient and short synthetic route to the structurally novel bimodal ligand NETA for antibody-targeted radiation therapy (radioimmunotherapy, RIT) of cancer was developed. The structure of NETA was determined by X-ray crystallography. The arsenazo-based UV spectroscopic complexation kinetics data suggest that NETA is a promising chelator for use in RIT applications of (212)Bi, (213)Bi, and (177)Lu.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18445528     DOI: 10.1016/j.bmcl.2008.03.084

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  12 in total

1.  Novel (64)Cu-radiolabeled bile acid conjugates for targeted PET imaging.

Authors:  Hyun-Soon Chong; Yunwei Chen; Chi Soo Kang; Xiang Sun; Ningjie Wu
Journal:  Bioorg Med Chem Lett       Date:  2015-01-12       Impact factor: 2.823

2.  Novel hexadentate and pentadentate chelators for ⁶⁴Cu-based targeted PET imaging.

Authors:  Inseok Sin; Chi Soo Kang; Nilantha Bandara; Xiang Sun; Yongliang Zhong; Buck E Rogers; Hyun-Soon Chong
Journal:  Bioorg Med Chem       Date:  2014-03-01       Impact factor: 3.641

3.  Synthesis and comparative biological evaluation of bifunctional ligands for radiotherapy applications of (90)Y and (177)Lu.

Authors:  Hyun-Soon Chong; Xiang Sun; Yunwei Chen; Inseok Sin; Chi Soo Kang; Michael R Lewis; Dijie Liu; Varyanna C Ruthengael; Yongliang Zhong; Ningjie Wu; Hyun A Song
Journal:  Bioorg Med Chem       Date:  2014-12-23       Impact factor: 3.641

4.  Preclinical evaluation of NETA-based bifunctional ligand for radioimmunotherapy applications using 212Bi and 213Bi: radiolabeling, serum stability, and biodistribution and tumor uptake studies.

Authors:  Chi Soo Kang; Hyun A Song; Diane E Milenic; Kwamena E Baidoo; Martin W Brechbiel; Hyun-Soon Chong
Journal:  Nucl Med Biol       Date:  2013-03-27       Impact factor: 2.408

5.  Convenient Synthesis and Evaluation of Heptadentate Bifunctional Ligand for Radioimmunotherapy Applications.

Authors:  Hyun-Soon Chong; Xiang Sun; Pengfei Dong; Chi Soo Kang
Journal:  European J Org Chem       Date:  2011-11-01

6.  Synthesis and evaluation of a new bifunctional NETA chelate for molecular targeted radiotherapy using(90)Y or(177)Lu.

Authors:  Chi Soo Kang; Yunwei Chen; Hyunbeom Lee; Dijie Liu; Xiang Sun; Junghun Kweon; Michael R Lewis; Hyun-Soon Chong
Journal:  Nucl Med Biol       Date:  2014-10-20       Impact factor: 2.408

7.  Novel bimodal bifunctional ligands for radioimmunotherapy and targeted MRI.

Authors:  Hyun-Soon Chong; Hyun A Song; Xiang Ma; Diane E Milenic; Erik D Brady; Sooyoun Lim; Haisung Lee; Kwamena Baidoo; Dengfeng Cheng; Martin W Brechbiel
Journal:  Bioconjug Chem       Date:  2008-06-20       Impact factor: 4.774

8.  Copper-64 radiolabeling and biological evaluation of bifunctional chelators for radiopharmaceutical development.

Authors:  Ravindra A De Silva; Sandeep Jain; Kimberly A Lears; Hyun-Soon Chong; Chi Soo Kang; Xiang Sun; Buck E Rogers
Journal:  Nucl Med Biol       Date:  2012-06-27       Impact factor: 2.408

Review 9.  Bismuth-213 for Targeted Radionuclide Therapy: From Atom to Bedside.

Authors:  Stephen Ahenkorah; Irwin Cassells; Christophe M Deroose; Thomas Cardinaels; Andrew R Burgoyne; Guy Bormans; Maarten Ooms; Frederik Cleeren
Journal:  Pharmaceutics       Date:  2021-04-21       Impact factor: 6.321

10.  Pyridine-containing octadentate ligand NE3TA-PY for formation of neutral complex with 177Lu(III) and 90Y(III) for radiopharmaceutical applications: Synthesis, DFT calculation, radiolabeling, and in vitro complex stability.

Authors:  Hyun-Soon Chong; Yunwei Chen; Chi Soo Kang; Inseok Sin; Shuyuan Zhang; Haixing Wang
Journal:  J Inorg Biochem       Date:  2021-04-24       Impact factor: 4.336

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.